Insulin pumps, continuous glucose monitoring products contributing to the delivery of hybrid closed loop pathways and associated products
| Source: | Find a Tender Service (FTS) |
| Buyer: | SUPPLY CHAIN COORDINATION LIMITED |
| Main Category: | Goods |
| Procurement Method: | — |
| Tender Status: | Planning |
| Estimated Value (ex. VAT): | £3,000,000,000 |
| Estimated Value (inc. VAT): | £3,600,000,000 |
| Release Date: | 6 February 2026 |
| Application Deadline: | 22 June 2026 |
| Contract Start Date: | 31 May 2027 (Estimated) |
| Contract End Date: | 27 May 2035 (Estimated) |
| Contract Duration: | 8.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-0649a1🔒 BidWriter |
| Notice Reference: | 010763-2026🔒 BidWriter |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Description
NHS Supply Chain supports national diabetes services by enabling equitable access to advanced diabetes technologies, encouraging openness to innovation, and ensuring an appropriate balance between clinical outcomes, cybersecurity, interoperability, and value for money. This notice is published to inform the market and to invite suppliers to participate in preliminary market engagement in accordance with the Procurement Act 2023. NHS Supply Chain is exploring the potential establishment of an open framework agreement with a proposed duration of up to eight (8) years for the supply of insulin pumps, continuous glucose monitoring (CGM) devices, hybrid closed loop system components, and associated products and services. The proposed scope may include, but is not limited to, tethered insulin pumps, patch insulin pumps, continuous glucose monitoring devices, products contributing to the functionality of hybrid closed loop insulin delivery systems, consumables, and smart insulin pens. Precise quantities are unknown. It is anticipated that indicative expenditure in the first year may be in the region of £240,000,000 to £250,000,000 GBP (excluding VAT). This estimate is indicative only and may vary depending on the requirements of contracting authorities accessing the framework. The estimated total value over the potential eight year duration is approximately £3,000,000,000 GBP (excluding VAT). Any future framework agreement would support delivery of the NHS England Implementation Plan following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 – Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes, published on 19 December 2023. Participation in this preliminary market engagement is voluntary and does not constitute a commitment by NHS Supply Chain to commence a procurement, to award a contract, or to include any participant in any future procurement process. Any future procurement will be conducted in accordance with the Procurement Act 2023 and published via the Find a Tender Service as appropriate. Any resulting framework agreement would be entered into between NHS Supply Chain and the appointed supplier(s)
Links & Documents
Apply Online
Proceed to the official portal to submit your bid.
Pipeline status
Not addedContract imported automatically · AI writes the response
Assign to team member
Delegate this bid in BidWriter
Run Bid / No Bid analysis
Score this opportunity in BidWriter
Sign in to BidWriter to sync favourites across devices
Application Deadline
22 June 2026
72 days left
Estimated Value
£3,000,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →